Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study

Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant... Am J Cardiovasc Drugs (2018) 18:117–127 https://doi.org/10.1007/s40256-017-0254-z ORIGINAL RESEARCH ARTICLE Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study 1 1 2,3 2 • • • • Yong Hoon Kim Ae-Young Her Seung-Woon Rha Byoung Geol Choi 2 2 3 2,3 • • • • Se Yeon Choi Jae Kyeong Byun Ahmed Mashaly Yoonjee Park 3 3 3 3 • • • • Won Young Jang Woohyeun Kim Jah Yeon Choi Eun Jin Park 3 3 3 3 3 • • • • • Jin Oh Na Cheol Ung Choi Hong Euy Lim Eung Ju Kim Chang Gyu Park 3 3 Hong Seog Seo Dong Joo Oh Published online: 15 November 2017 Springer International Publishing AG 2017 Abstract Conclusions Additional long-term (5-year) treatment with Objective We aimed to evaluate the additive benefit of trimetazidine in combination with diltiazem and nitrate in trimetazidine with well-known antispasmodic agents such patients with significant CAS was not associated with as calcium channel blockers and nitrate in patients with improved clinical outcomes compared with combination significant coronary artery spasm (CAS) as assessed by therapy with diltiazem and nitrate only (without acetylcholine provocation test http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study

Loading next page...
 
/lp/springer_journal/impact-of-trimetazidine-treatment-on-5-year-clinical-outcomes-in-3tDE6jdOmt
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
D.O.I.
10.1007/s40256-017-0254-z
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs (2018) 18:117–127 https://doi.org/10.1007/s40256-017-0254-z ORIGINAL RESEARCH ARTICLE Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study 1 1 2,3 2 • • • • Yong Hoon Kim Ae-Young Her Seung-Woon Rha Byoung Geol Choi 2 2 3 2,3 • • • • Se Yeon Choi Jae Kyeong Byun Ahmed Mashaly Yoonjee Park 3 3 3 3 • • • • Won Young Jang Woohyeun Kim Jah Yeon Choi Eun Jin Park 3 3 3 3 3 • • • • • Jin Oh Na Cheol Ung Choi Hong Euy Lim Eung Ju Kim Chang Gyu Park 3 3 Hong Seog Seo Dong Joo Oh Published online: 15 November 2017 Springer International Publishing AG 2017 Abstract Conclusions Additional long-term (5-year) treatment with Objective We aimed to evaluate the additive benefit of trimetazidine in combination with diltiazem and nitrate in trimetazidine with well-known antispasmodic agents such patients with significant CAS was not associated with as calcium channel blockers and nitrate in patients with improved clinical outcomes compared with combination significant coronary artery spasm (CAS) as assessed by therapy with diltiazem and nitrate only (without acetylcholine provocation test

Journal

American Journal of Cardiovascular DrugsSpringer Journals

Published: Nov 15, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off